scPharmaceuticals Inc SCPH:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/15/22 EDT
6.47quote price arrow up+0.32 (+5.20%)
Volume
77,068
52 week range
3.48 - 7.24
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.47
  • 52 Week High7.24
  • 52 Week High Date09/22/21
  • 52 Week Low3.48
  • 52 Week Low Date12/03/21

Key Stats

  • Market Cap177.28M
  • Shares Out27.40M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change28.88

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.47
  • 52 Week High7.24
  • 52 Week High Date09/22/21
  • 52 Week Low3.48
  • 52 Week Low Date12/03/21
  • Market Cap177.28M
  • Shares Out27.40M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change28.88

RATIOS/PROFITABILITY

  • EPS (TTM)-1.33
  • P/E (TTM)-4.88
  • Fwd P/E (NTM)-4.25
  • EBITDA (TTM)-29.251M
  • ROE (TTM)-57.17%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)30.44%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On scPharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infusor and...
Jack Khattar
Independent Chairman of the Board
John Tucker
President, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer, Director
Address
2400 District Avenue, Suite 310
Burlington, MA
01803
United States

Top Peers

SYMBOLLASTCHG%CHG
CRMD
CorMedix Inc
4.13-0.02-0.48%
DRRX
DURECT Corp
0.91+0.13+16.67%
SEEL
Seelos Therapeutics Inc
0.9755+0.0256+2.70%
INFI
Infinity Pharmaceuticals Inc
1.27+0.12+10.43%
GTBP
GT Biopharma Inc
2.75UNCHUNCH